These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 7071412)

  • 1. Functional and structural changes in the rat kidney by long-term lithium treatment.
    Christensen S; Hansen BB; Faarup P
    Ren Physiol; 1982; 5(2):95-104. PubMed ID: 7071412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe functional and structural changes caused by lithium in the developing rat kidney.
    Christensen S; Ottosen PD; Olsen S
    Acta Pathol Microbiol Immunol Scand A; 1982 Jul; 90(4):257-67. PubMed ID: 7124397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenesis of nephrogenic diabetes insipidus due to chronic administration of lithium in rats.
    Christensen S; Kusano E; Yusufi AN; Murayama N; Dousa TP
    J Clin Invest; 1985 Jun; 75(6):1869-79. PubMed ID: 2989335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of long-term lithium administration on renal structure and function in rats. A distinctive tubular lesion.
    Kling MA; Fox JG; Johnston SM; Tolkoff-Rubin NE; Rubin RH; Colvin RB
    Lab Invest; 1984 May; 50(5):526-35. PubMed ID: 6716969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium-induced NDI: acetazolamide reduces polyuria but does not improve urine concentrating ability.
    de Groot T; Doornebal J; Christensen BM; Cockx S; Sinke AP; Baumgarten R; Bedford JJ; Walker RJ; Wetzels JFM; Deen PMT
    Am J Physiol Renal Physiol; 2017 Sep; 313(3):F669-F676. PubMed ID: 28615247
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered expression of renal AQPs and Na(+) transporters in rats with lithium-induced NDI.
    Kwon TH; Laursen UH; Marples D; Maunsbach AB; Knepper MA; Frokiaer J; Nielsen S
    Am J Physiol Renal Physiol; 2000 Sep; 279(3):F552-64. PubMed ID: 10966935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of lithium and neuroleptics and combinations of the two on renal function and structure in rats.
    Christensen S; Kristensen AR; Faarup P
    Acta Pharmacol Toxicol (Copenh); 1981 Sep; 49(3):161-7. PubMed ID: 6121456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of lithium on water intake and renal concentrating ability in rats with vasopressin-deficient diabetes insipidus (Brattleboro strain).
    Christensen S
    Pflugers Arch; 1983 Feb; 396(2):106-9. PubMed ID: 6835812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional and structural rat kidney changes caused by peroral or parenteral lithium treatment.
    Plenge P; Mellerup ET; Nørgaard T
    Acta Psychiatr Scand; 1981 Apr; 63(4):303-13. PubMed ID: 7315479
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the mechanism of lithium-induced diabetes insipidus in man and the rat.
    Forrest JN; Cohen AD; Torretti J; Himmelhoch JM; Epstein FH
    J Clin Invest; 1974 Apr; 53(4):1115-23. PubMed ID: 4360856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy.
    Boton R; Gaviria M; Batlle DC
    Am J Kidney Dis; 1987 Nov; 10(5):329-45. PubMed ID: 3314489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium nephrotoxicity.
    Walker RG
    Kidney Int Suppl; 1993 Jul; 42():S93-8. PubMed ID: 8361139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithium-induced morphological changes in the rat kidney at different levels of urine flow.
    Ottosen PD; Jacobsen NO; Christensen S
    Pharmacol Toxicol; 1988 Aug; 63(2):108-13. PubMed ID: 3186616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent nephrogenic diabetes insipidus associated with long-term lithium carbonate treatment.
    Rabin EZ; Garston RG; Weir RV; Posen GA
    Can Med Assoc J; 1979 Jul; 121(2):194-8. PubMed ID: 519597
    [No Abstract]   [Full Text] [Related]  

  • 15. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y; Peti-Peterdi J; Müller CE; Carlson NG; Baqi Y; Strasburg DL; Heiney KM; Villanueva K; Kohan DE; Kishore BK
    J Am Soc Nephrol; 2015 Dec; 26(12):2978-87. PubMed ID: 25855780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The renal pathology in a case of lithium-induced diabetes insipidus.
    Lindop GB; Padfield PL
    J Clin Pathol; 1975 Jun; 28(6):472-5. PubMed ID: 1141447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lithium-induced nephrogenic diabetes insipidus: in vivo and in vitro studies.
    Singer I; Rotenberg D; Puschett JB
    J Clin Invest; 1972 May; 51(5):1081-91. PubMed ID: 4341501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amelioration of polyuria by amiloride in patients receiving long-term lithium therapy.
    Batlle DC; von Riotte AB; Gaviria M; Grupp M
    N Engl J Med; 1985 Feb; 312(7):408-14. PubMed ID: 3969096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of lithium treatment on rat renal tubule function. Evidence against impaired antidiuretic hormone action.
    Carney SL; Wong NL; Dirks JH
    Nephron; 1980; 25(6):294-8. PubMed ID: 7393371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium-induced polyuria: effect of lithium on adenylate cyclase and adenosine 3',5'-monophosphate phosphodiesterase in medullary ascending limb of Henle's loop and in medullary collecting tubules.
    Jackson BA; Edwards RM; Dousa TP
    Endocrinology; 1980 Dec; 107(6):1693-8. PubMed ID: 6253274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.